Pacs Group, INC Form 4 insider transactions

NYSE
PACS Group, Inc. director Patrick Hugh Conway was granted 3,497 restricted stock units, aligning his interests with shareholders.
NYSE
PACS Group's Chief Compliance Officer, Kelly Priegnitz, was granted 30,000 restricted stock units vesting over three years.
NYSE
PACS Group's Chief Human Resources Officer, Trent Dean Bingham, was granted 25,000 restricted stock units vesting over three years.
NYSE
PACS Group's Chief Accounting Officer, Michelle Renee Lewis, disposed of 3,348 shares of common stock to cover tax liabilities from vested restricted stock units.
NYSE
PACS Group's Chief Legal Officer, John Todd Mitchell, disposed of 9,541 common shares to cover tax liabilities from vested restricted stock units.
NYSE
PACS Group's President and COO, Joshua Jergensen, disposed of 21,998 common shares to cover tax liabilities related to restricted stock unit vesting.
NYSE
Mark Hancock, a Director and 10% owner of PACS Group, Inc., disposed of 12,774 shares of common stock to cover tax liabilities.
NYSE
PACS Group's Co-Founder, CEO, and Chairman, Jason Hulse Murray, disposed of 20,082 shares of common stock to cover tax liabilities related to restricted stock unit vesting.
NYSE
PACS Group, Inc. Director Taylor S. Leavitt reported the acquisition of 4,399 restricted stock units, vesting by December 2026.
NYSE
PACS Group, Inc. Director Evelyn S. Dilsaver was granted 4,399 restricted stock units, increasing her beneficial ownership to 27,138 shares.
NYSE
PACS Group Director Jacqueline Millard was granted 4,399 restricted stock units, aligning her interests with shareholders.
NYSE
PACS Group, Inc. has granted 51,627 restricted stock units to its Chief Accounting Officer, Michelle Renee Lewis, as part of a long-term incentive plan.
NYSE
PACS Group's Chief Legal Officer and Secretary, John Todd Mitchell, was granted 121,855 restricted stock units (RSUs) on December 17, 2025, as part of his compensation.
NYSE
PACS Group's President & COO, Joshua Jergensen, was granted 216,018 restricted stock units, increasing his beneficial ownership.
NYSE
PACS Group, Inc. reported the grant of 191,018 restricted stock units to Co-Founder and Executive Vice Chair Mark Hancock, aligning executive incentives with long-term company performance.
NYSE
PACS Group, Inc. Co-Founder, CEO, and Chairman Jason Hulse Murray acquired 241,018 restricted stock units, increasing his direct beneficial ownership.
NYSE
PACS Group, Inc. Director Evelyn S. Dilsaver acquired 16,724 shares of common stock at a weighted average price of $29.897 per share.
NYSE
PACS Group's Chief Legal Officer, John Todd Mitchell, sold 159,556 shares of common stock for approximately $29.89 per share.
NYSE
Michelle Renee Lewis, Chief Accounting Officer of PACS Group, Inc., reports the withholding of shares to cover tax liabilities upon vesting of restricted stock units.
NYSE
Joseph Robert Lee, Chief Compliance Officer of PACS Group, reports the withholding of shares to cover tax liabilities upon vesting of restricted stock units.
NYSE
Peter Sanford, an officer at PACS Group, disposed of 72,924 shares of common stock on April 15, 2025, to cover tax liabilities associated with vesting restricted stock units.
NYSE
John Mitchell, Chief Legal Officer & Secretary of PACS Group, reports disposition of shares to cover tax liabilities upon vesting of restricted stock units.
NYSE
Derick G. Apt, CFO of PACS Group, sold shares to cover tax liabilities arising from the vesting of restricted stock units.
NYSE
Joshua Jergensen, President & COO of PACS Group, reports the withholding of shares to cover tax liabilities upon vesting of restricted stock units.
NYSE
Mark Hancock, Co-Founder and Executive Vice Chair of PACS Group, Inc., reports the sale of 8,128,352 shares of common stock at $36.25 per share.
NYSE
Jason Hulse, Co-Founder, CEO & Chairman of PACS Group, sold 8,128,352 shares of common stock at $36.25 per share on September 9, 2024.
NYSE
Evelyn S. Dilsaver, a director of PACS Group, Inc., reported acquiring 5,927 shares of common stock on May 9, 2024, through restricted stock units.
NYSE
Director Taylor S. Leavitt acquired 6,438 restricted stock units (RSUs) of PACS Group, Inc. on May 9, 2024, which will vest on May 9, 2025.
NYSE
Director Jacqueline Millard reports acquiring common stock and restricted stock units in PACS Group, Inc.
NYSE
Chief Financial Officer Derick G. Apt of PACS Group, Inc. reports the acquisition of restricted stock units and a subsequent disposal of shares to cover tax obligations.